Exelixis
EXEL
#1797
Rank
$11.08 B
Marketcap
$41.17
Share price
-0.51%
Change (1 day)
14.14%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company